促排卵治疗对高催乳素血症不孕患者疗程的影响OACSTPCD
Ovulation induction drug impact to the course of hyper-prolactinemia infertility treatment
目的:探讨高催乳素血症(hyperprolactinemia,HPRL)不孕患者药物治疗方案及效果.方法:回顾分析垂体微腺瘤引起的HPRL不孕患者70例,根据治疗方案不同分为两组.溴隐亭组38例单用溴隐亭治疗,初始剂量1.25 mg/d,后加量使催乳素水平正常后逐渐减量至溴隐亭维持量为1.25～2.5 mg/d,不用促排卵药物.联合用药组32例,溴隐亭初始剂量同溴隐亭组,用维持量后于月经第3-5天加用枸橼酸氯米芬促排卵治疗,枸橼酸氯米芬用药期间溴…查看全部>>
Objective:To investigate the therapeutic drugs scheme and their efficacy to the infertility patients with hyper-prolactinemia( HPRL). Methods: Seventy cases of infertility patients with HPRL treated in out-patient department of gynecology were analysed retrospectively. They were divided two groups according their different therapeutic schemes: Group I ( n = 38 ) , used bromocriptine mesylate only, 1. 25 mg/d, at the beginning, and increased gradually until t…查看全部>>
陈嫣;王秀娣
江苏大学附属医院妇产科,江苏,镇江,212001江苏大学附属医院妇产科,江苏,镇江,212001
医药卫生
高催乳素血症不孕症溴隐亭促排卵治疗效果垂体微腺瘤
hyperprolactinemia infertility bromocriptine ovulation induction therapeutic efficacy pituitary microadenoma
《江苏大学学报（医学版）》 2011 (5)
402-404,3
评论